We are live on ! Find out more
AGN.PRA

Allergan plc
AGN.PRA

Delisted

AGN.PRA was delisted on the 28th of February, 2018.

Back to rankings

1 hedge funds and large institutions have $3.04M invested in Allergan plc in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $2.69M → $3.04M (+$350K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PWS
Peloton Wealth Strategists
Indiana
+$375K

Top Sellers

No sellers this quarter

AGN.PRA Hedge Fund Activity: Q2 2018 in Review

1 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q2 2018, worth a combined $3.04M — up 13% from $2.69M a quarter earlier.

Fund positioning in AGN.PRA was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Peloton Wealth Strategists, adding an estimated $375K.

  • 1 institutional investor held Allergan plc (AGN.PRA) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $3.04M of Allergan plc stock for Q2 2018, up 13% quarter-over-quarter.
  • 0 funds opened new Allergan plc positions in Q2 2018 and 0 closed out.
  • The largest Allergan plc buyer in Q2 2018 was Peloton Wealth Strategists, an estimated $375K added.

Based on aggregated 13F filings for Q2 2018.